Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2021-04-01

Clinical Trial Update: Paclitaxel, Polyglutamate Paclitaxel, or Observation in Treating Patients With Stage III or Stage IV Ovarian Epithelial, Peritoneal Cancer, or Fallopian Tube Cancer [Phase 3]

View source ↗

Summary

Phase 3 trial evaluating paclitaxel, polyglutamate paclitaxel, or observation in advanced ovarian, fallopian tube, or primary peritoneal cancer; status and resu…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • PACLITAXEL (PACLITAXEL)
  • polyglutamate paclitaxel (not specified)

Snippet

Sponsor: GOG Foundation | Conditions: Fallopian Tube Clear Cell Adenocarcinoma, Fallopian Tube Endometrioid Adenocarcinoma | Phase 3 | Status: UNKNOWN | Results posted: 2021-04-01